Prudential Financial’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-47,661
| Closed | -$3.71M | – | 2306 |
|
2024
Q3 | $3.71M | Sell |
47,661
-536
| -1% | -$41.8K | 0.01% | 1130 |
|
2024
Q2 | $3.76M | Buy |
48,197
+10,627
| +28% | +$829K | 0.01% | 1050 |
|
2024
Q1 | $2.55M | Sell |
37,570
-141
| -0.4% | -$9.55K | ﹤0.01% | 1298 |
|
2023
Q4 | $2.54M | Buy |
37,711
+6,494
| +21% | +$437K | ﹤0.01% | 1289 |
|
2023
Q3 | $2.11M | Buy |
31,217
+1,178
| +4% | +$79.8K | ﹤0.01% | 1334 |
|
2023
Q2 | $2.15M | Sell |
30,039
-166
| -0.5% | -$11.9K | ﹤0.01% | 1362 |
|
2023
Q1 | $1.99M | Buy |
30,205
+14,340
| +90% | +$946K | ﹤0.01% | 1350 |
|
2022
Q4 | $1.08M | Sell |
15,865
-3,238
| -17% | -$220K | ﹤0.01% | 1669 |
|
2022
Q3 | $1.05M | Buy |
19,103
+5,554
| +41% | +$305K | ﹤0.01% | 1730 |
|
2022
Q2 | $908K | Sell |
13,549
-2,771
| -17% | -$186K | ﹤0.01% | 1840 |
|
2022
Q1 | $1.08M | Buy |
16,320
+620
| +4% | +$41.1K | ﹤0.01% | 1836 |
|
2021
Q4 | $1M | Sell |
15,700
-300
| -2% | -$19.1K | ﹤0.01% | 1879 |
|
2021
Q3 | $889K | Buy |
16,000
+5,845
| +58% | +$325K | ﹤0.01% | 1871 |
|
2021
Q2 | $608K | Buy |
10,155
+969
| +11% | +$58K | ﹤0.01% | 2064 |
|
2021
Q1 | $457K | Buy |
9,186
+3,086
| +51% | +$154K | ﹤0.01% | 2159 |
|
2020
Q4 | $305K | Sell |
6,100
-1,747
| -22% | -$87.4K | ﹤0.01% | 2240 |
|
2020
Q3 | $430K | Buy |
7,847
+2,884
| +58% | +$158K | ﹤0.01% | 2010 |
|
2020
Q2 | $262K | Buy |
+4,963
| New | +$262K | ﹤0.01% | 2156 |
|
2020
Q1 | – | Sell |
-4,935
| Closed | -$246K | – | 2355 |
|
2019
Q4 | $246K | Buy |
+4,935
| New | +$246K | ﹤0.01% | 2270 |
|